FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Eric Swalwell, Man Who Quit Congress In Part Due to Improper Contact With Staffers on Snapchat, Still Contacting Staffers on Snapchat

Trump administration to close Potomac golf course for championship-level renovations

After Spirit Airlines Goes Bust, Remember How Biden, Warren Stopped Merger to Save Airline Because It’d Mean ‘Fewer Flights’

Trump troop cuts in Europe could be blocked by Congress — here’s how he might get around it

Communist and socialist groups call for ‘revolution’ and seizure of property at Minneapolis May Day rally

Female Accused Would-Be Trump Assassin Walks Free Days After Third Assassination Attempt

Trump Greenlights ‘Keystone Light’ Pipeline to Help Replace Oil Source Infamously Blocked on Biden’s Day 1

ICE lines up to boot illegal immigrant child sex predator after bogus asylum claim, early prison release

Power the future sends letter to lawmakers over data

Beloved crossing guard killed by alleged drunk driver while helping kids cross the street in Louisiana

Mamdani allocates $500K for reparations talks as NYC faces $5.4B deficit

‘New Democrat party’: Senate GOP sounds off on ‘extreme’ Graham Platner as Senate race in Maine heats up

Would-Be Trump Assassin Wasn’t Only One Encountering ‘Insane’ Security Arrangement at Glitzy Dinner

Dr. Oz names 5 states in fraud crackdown as Trump admin targets Medicaid abuse

Report: Biden Admin Hid Planned Parenthood Loan Discussions Using Code Word ‘Benghazi’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”